What Semaglutide Really Costs in 2026

Semaglutide price by channel: the full table

Five distinct prices exist for the same molecule right now. Here is the complete 2026 picture, from most to least expensive:

List prices are manufacturer figures before any discounts; actual pharmacy shelf prices vary by a few percent. Copay range assumes a plan that covers weight loss medication, which many still exclude.

The four levers that set your personal price

Your number inside that $99–$1,349 range is decided by four factors, in this order of impact:

• Coverage status. A plan that covers Wegovy turns a $1,349 drug into a $25–$50 copay. A plan that excludes weight loss medication, which remains common in 2026, pushes you straight to cash-pay pricing.
• Channel. Cash payers who buy at a retail counter pay list. The same cash payer using NovoCare pays $499. The gap is $850 a month for identical pens.
• Brand vs compounded. Compounded semaglutide from a licensed pharmacy cuts the floor to roughly $99–$299, with trade-offs covered in our compounded vs brand comparison.
• Dose, sometimes. NovoCare charges $499 flat at every dose. Many compounded programs, by contrast, price 1 mg cheaper than 2.4 mg, so titrating up can raise your bill.

The $499 flat rate from NovoCare, explained

Novo Nordisk's direct channel is the single biggest price development for cash payers. Through NovoCare Pharmacy, self-pay patients get brand-name Wegovy or Ozempic shipped for $499 a month at every dose level, from the 0.25 mg starter through the full 2.4 mg maintenance dose of Wegovy.

Three details matter for your budgeting. First, it is genuine brand product in the original pens, not a substitute. Second, the flat rate means titration never changes your bill, which makes the first year predictable at $5,988. Third, it requires a valid prescription and self-pay status; it is a cash program, not an insurance benefit. For a cash payer who wants the FDA-approved finished product, this is the benchmark price every alternative should be measured against.

Compounded semaglutide: the $99–$299 floor and its fine print

Compounded semaglutide is the cheapest way to take the molecule, typically $99 to $299 a month through telehealth programs that bundle the prescription visit and shipping.

The regulatory context changed, and honest math requires it. The FDA declared the semaglutide shortage resolved in February 2025, which ended the window when compounding pharmacies could mass-produce copies of the brand product under 503A rules. Access now runs through personalized, prescriber-specific formulations via telehealth, and availability is more tightly policed than it was in 2023–2024. Legitimate programs use licensed US pharmacies and physician oversight; prices dramatically below $99 a month are a red flag worth treating seriously. Our guide to the cheapest semaglutide options ranks the vetted routes in detail.

The 12-month math, including titration

Semaglutide is not a one-month purchase. Trial protocols titrate from 0.25 mg up to 2.4 mg over several months, and the STEP-1 trial measured its roughly 15% average weight loss at 68 weeks. Budgeting for a year is the realistic frame:

• Insurance with coverage: $300–$600 a year in copays, the clear winner when available.
• Compounded telehealth: roughly $1,188–$3,588 a year depending on program and dose.
• NovoCare self-pay: $5,988 a year, flat and predictable.
• Retail list price: $11,976–$16,188 a year, a price almost nobody should actually pay in 2026.

Two cost lines sit outside the medication itself and deserve a place in the annual math. Provider visits: telehealth programs typically bundle them into the monthly price, but a standalone prescription filled through NovoCare means separate consultations, often $100–$200 across a year when insurance does not pick them up. Supplies: vial-based routes add syringes, alcohol swabs, and sharps disposal, cheap individually but a real line item over twelve months. The clean comparison between two offers is always the all-in annual number, medication plus visits plus supplies, which is how the figures above should be read.

One more variable moves the total quietly: dose changes and pauses. Some people hold at a lower maintenance dose than 2.4 mg with their prescriber's agreement, which trims cost on dose-priced programs, while months missed to shipping gaps or refill authorizations shift spending later rather than saving it. A twelve-month view absorbs that noise; a single-month price comparison hides it.

HSA and FSA funds can be applied to any of these when prescribed, which effectively discounts the bill by your marginal tax rate.

How to land at the bottom of the range

The sequence that minimizes cost is mechanical. Check your plan documents for weight loss medication coverage first, because a $25 copay beats every cash option. If excluded, price NovoCare's $499 flat rate as your brand benchmark. Then compare vetted compounded programs at $99–$299 if the vial format and 503A framework fit your comfort level. Whether you meet the standard criteria in the first place, a BMI of 30 or more, or 27 plus a weight-related condition, is something a licensed provider confirms; you can check the insurance playbook or take the two-minute eligibility assessment before pricing anything.

If you want the telehealth route priced for your situation, compare current semaglutide program pricing here.